Summary
Alex Beatson is a machine learning entrepreneur and researcher with nine years of experience applying generative models, active learning, and physics-informed ML to molecular design and safety. As Co-Founder of Axiom Bio he’s focused on using AI to surface drug toxicity earlier and more cheaply, building on prior leadership at Redesign Science and R&D roles at Genesis Therapeutics where he engineered platforms for molecule generation, inference at scale, and ML-accelerated simulation. His background includes Google Brain internships working on large-scale generative model training and a PhD in Computer Science from Princeton, giving him a strong mix of academic rigor and production ML systems experience. Based in San Francisco, he blends deep technical know-how in GNNs, language models for chemistry, and scalable inference pipelines with a knack for translating complex scientific problems into pragmatic engineering products. An under-the-radar strength is his cross-disciplinary foundation in mechatronics engineering, which informs practical engineering-first solutions to computational chemistry challenges.
9 years of coding experience
2 years of employment as a software developer
BE(Hons) Mechatronics Engineering, BE(Hons) Mechatronics Engineering at University of Canterbury
Doctor of Philosophy (Ph.D.) Computer Science, Doctor of Philosophy (Ph.D.) Computer Science at Princeton University
Chinese, German, English